Azasite
Product Images NDC 17478-307

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Azasite (NDC 17478-307). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aza00 0005 01

Chemical structure of the active ingredient in AzaSITE, illustrating its molecular composition and arrangement of atoms, including multiple hydroxyl groups and a nitrogen-containing ring.*

FDA Label Image

Aza00 0005 02

The image shows a medication administration schedule for AzaSITE, detailing the dosing instructions from Day 1 through Day 7. It includes directions for morning and evening drops for the first two days, followed by instructions for one drop anytime during the day for Days 3 to 7. The format is a checklist with spaces to mark the days and doses given.*

FDA Label Image

Aza00 0005 03

Illustration showing a hand holding an eye drop bottle and gently pulling down the lower eyelid of the opposite hand in preparation to apply eye drops. The image is labeled Figure A and demonstrates the proper technique for administering eye drops.*

FDA Label Image

Aza00 0005 04

An instructional illustration showing the proper technique to remove the protective seal from a dropper bottle, with one hand holding the bottle and the other hand pulling the seal tab upward. This is related to the use of AzaSITE by Akorn.*

FDA Label Image

Aza00 0005 05

An instructional illustration showing a hand holding a small bottle, with an arrow indicating the action of twisting or turning the cap. This likely depicts how to open or prepare the bottle for use.*

FDA Label Image

Aza00 0005 06

An instructional illustration showing a hand holding a small dropper bottle above an open eye, guiding how to apply eye drops.*

FDA Label Image

Aza00 0005 07

An instructional illustration showing hands removing a cap from a small bottle, demonstrating the proper way to open the AzaSITE bottle by lifting the cap upwards with fingers.*

FDA Label Image

Aza00 0005 08

An instructional illustration showing a hand holding an eye dropper above an eye, demonstrating the proper technique for administering eye drops by gently pulling down the lower eyelid to create a pouch for the drops.*

FDA Label Image

Aza00 0005 09

AzaSITE (azithromycin ophthalmic solution) 1% label showing the product name and active ingredient. It indicates a sterile 2.5 mL multi-dose bottle labeled for prescription use only. The label includes the NDC number 17478-307-03 and the Akorn labeler code STW-AK50300.*

FDA Label Image

Aza00 0005 10

Packaging label for AzaSITE (azithromycin ophthalmic solution) 1%, sterile 2.5 mL, distributed by Akorn, Inc. The label includes dosage instructions, storage conditions, a list of inactive ingredients, and the NDC 17478-307-03. The design features blue and green text with a blue wave graphic on a white background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.